CASI logo

CASI Pharmaceuticals, Inc. (CASI)

Profile

Full Name

CASI Pharmaceuticals, Inc.

Ticker

NASDAQ: CASI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

China

IPO

June 12, 1996

Indexes

Not included

Website

http://www.casipharmaceuticals.com

Employees

233

Key Details

Price

$1.48(+4.23%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$28.54M(-15.77% YoY)

Annual EPS

-$2.56(-26.73% YoY)

PE ratio

-

Next earnings date

Aug 20, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.48
    CASI price is $1.48

    30-Day Relative Volume

    0.28
    CASI 30-day relative volume is 0.28

    Price Performance

    Price Most recent change

    +4.23%
    CASI price was up +4.23% on Jul 25, 2025

    Price YTD change

    -47.7%
    CASI price is down -47.7% since January 1st

    Price 1-year change

    -77.68%
    CASI price is down -77.68% year-on-year

    Price 3-year change

    -44.98%
    CASI price is down -44.98% over the past 3 years

    Price Range

    Price All-time high

    $11137.50
    CASI price is currently -99.99% below its historical high of $11137.50

    Price 3-year low

    $1.09
    CASI price is currently +35.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $22.93M
    CASI market capitalization is $22.93 million

    Market cap 3-year change

    -37.35%
    CASI market capitalization is down -37.35% over the past 3 years

    Market cap All-time high

    $1.42B
    CASI market capitalization is currently -98.39% below its historical high of $1.42 billion

    Market cap sector rank

    25.06%
    CASI market capitalization is higher than 25.06% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.22%
    CASI shares outstanding is up +0.22% year-on-year

    Shares Outstanding 3-Year Change

    +13.87%
    CASI shares outstanding is up +13.87% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.52
    CASI beta is 0.52

    200-day SMA

    $2.83
    CASI price is currently -47.72% below its 200-day simple moving average

    50-day SMA

    $1.57
    CASI price is currently -5.80% below its 50-day simple moving average

    RSI

    54.80
    CASI 14-day relative strength index is 54.80

    Volume

    0.28
    CASI 30-day relative volume is 0.28

    ATR

    $0.14
    CASI average true range is $0.14

    10-day Historical Volatility

    81.13%
    CASI 10-day historical volatility is 81.13%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $28.54M
    CASI annual revenue is $28.54 million

    Revenue Analysts estimate

    $12.52M
    CASI annual revenue is currently +128.02% higher than the consensus analysts' forecast

    Revenue 1-year change

    -15.77%
    CASI annual revenue is down -15.77% year-on-year

    Revenue Sector rank

    37.94%
    CASI annual revenue is higher than 37.94% of companies in Healthcare sector

    EPS

    EPS

    -$2.56
    CASI annual earnings per share is -$2.56

    EPS Analysts estimate

    -
    CASI annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -26.73%
    CASI annual earnings per share is down -26.73% year-on-year

    EPS Sector rank

    34.52%
    CASI annual earnings per share is higher than 34.52% of companies in Healthcare sector

    Profit

    Gross profit

    $11.15M
    CASI annual gross profit is $11.15 million

    Gross margin

    39.06%
    CASI annual gross profit margin is 39.06%

    Operating profit

    -$39.21M
    CASI annual operating income is -$39.21 million

    Operating margin

    -137.41%
    CASI annual operating profit margin is -137.41%

    Net income

    -$39.26M
    CASI annual net profit is -$39.26 million

    Net margin

    -137.57%
    CASI annual net profit margin is -137.57%

    Expenses

    Total expenses

    $67.75M
    CASI annual total expenses is $67.75 million

    Operating expenses

    $50.36M
    CASI annual total operating expenses is $50.36 million

    Cost of goods sold

    $17.39M
    CASI annual cost of goods sold is $17.39 million

    Selling, general & administrative expenses

    $41.44M
    CASI annual SGA is $41.44 million

    Depreciation and amortization

    $2.33M
    CASI annual depreciation & amortization is $2.33 million

    Interest expense

    $871.00K
    CASI annual interest expense is $871.00 thousand

    Income tax

    $0.00
    CASI annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$37.20M
    CASI annual earnings before interest & taxes is -$37.20 million

    EBITDA

    -$34.87M
    CASI annual EBITDA is -$34.87 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $53.67M
    CASI annual total assets is $53.67 million

    Non current assets

    $13.90M
    CASI annual long term assets is $13.90 million

    Current assets

    $39.58M
    CASI annual total current assets is $39.58 million

    Cash and cash equivalents

    $13.47M
    CASI annual cash & cash equivalents is $13.47 million

    Accounts receivable

    $15.35M
    CASI annual accounts receivable is $15.35 million

    Inventory

    $5.25M
    CASI annual inventory is $5.25 million

    Liabilities

    Total liabilities

    $51.82M
    CASI annual total liabilities is $51.82 million

    Long term liabilities

    $15.37M
    CASI annual total long term liabilities is $15.37 million

    Current liabilities

    $36.45M
    CASI annual total current liabilities is $36.45 million

    Accounts payable

    $2.72M
    CASI annual accounts payable is $2.72 million

    Debt

    Total debt

    $22.14M
    CASI annual total debt is $22.14 million

    Total debt 1-year change

    +4.25%
    CASI annual total debt is up +4.25% year-on-year

    Long term debt

    $2.54M
    CASI annual long term debt is $2.54 million

    Short term debt

    $19.61M
    CASI annual short term debt is $19.61 million

    Equity & Capital

    Shareholders equity

    $1.85M
    CASI annual stockholders equity is $1.85 million

    Book value

    $1.85M
    CASI annual book value is $1.85 million

    Retained earnings

    -$700.08M
    CASI annual retained earnings is -$700.08 million

    Working capital

    $3.12M
    CASI annual working capital is $3.12 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$29.22M
    CASI annual cash flow from operations is -$29.22 million

    Cash from operations 1-year change

    -46.36%
    CASI annual cash flow from operations is down -46.36% year-on-year

    Cash from investing

    $11.24M
    CASI annual cash flow from investing activities is $11.24 million

    Cash from investing 1-year change

    +216.24%
    CASI annual cash flow from investing activities is up +216.24% year-on-year

    Cash from financing

    $15.43M
    CASI annual cash flow from financing activities is $15.43 million

    Cash from financing 1-year change

    +1801.65%
    CASI annual cash flow from financing activities is up +1801.65% year-on-year

    CAPEX

    CAPEX

    $240.00K
    CASI annual capital expenditures is $240.00 thousand

    CAPEX 1-year change

    -89.29%
    CASI annual capital expenditures is down -89.29% year-on-year

    Free Cash Flow

    Free cash flow

    -$29.46M
    CASI annual free cash flow is -$29.46 million

    Free cash flow 1-year change

    -32.67%
    CASI annual free cash flow is down -32.67% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    39.06%
    CASI annual gross profit margin is 39.06%

    Operating margin

    -137.41%
    CASI annual operating profit margin is -137.41%

    Net margin

    -137.57%
    CASI annual net profit margin is -137.57%

    ROA & ROE

    ROA

    -60.89%
    CASI annual return on assets is -60.89%

    ROE

    -301.80%
    CASI annual return on equity is -301.80%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CASI price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CASI price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -2.84
    CASI price to book ratio is -2.84

    PB ratio Sector rank

    6.95%
    CASI price to book ratio is higher than 6.95% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.73
    CASI price to sales ratio is 0.73

    PS ratio Sector rank

    18.8%
    CASI price to sales ratio is higher than 18.8% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $30.52M
    CASI enterprise value is $30.52 million

    Enterprise value Sector rank

    30.69%
    CASI enterprise value is higher than 30.69% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.79
    CASI EV/EBITDA is -0.79

    EV/EBITDA Sector rank

    53.35%
    CASI EV/EBITDA is higher than 53.35% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.09
    CASI annual current ratio is 1.09

    Quick ratio

    0.94
    CASI annual quick ratio is 0.94

    Leverage

    Debt to equity

    9.93
    CASI annual debt to equity ratio is 9.93

    Interest coverage ratio

    -42.71
    CASI annual interest coverage ratio is -42.71

    Risk & Stability

    Piotroski F-Score

    -
    CASI piotroski f-score value is unknown

    Altman Z-Score

    -19.68
    CASI altman z-score is -19.68

    Analyst ratings

    Recent major analysts updates

    May 19, 25 HC Wainwright & Co.
    Buy
    Apr 9, 25 HC Wainwright & Co.
    Buy
    May 15, 24 HC Wainwright & Co.
    Buy
    Nov 15, 23 HC Wainwright & Co.
    Buy
    Aug 14, 23 HC Wainwright & Co.
    Buy
    May 22, 23 HC Wainwright & Co.
    Buy
    Nov 16, 22 BTIG
    Buy
    Nov 15, 22 HC Wainwright & Co.
    Buy
    Aug 15, 22 HC Wainwright & Co.
    Buy
    Jun 3, 22 BTIG
    Buy

    Institutional Ownership

    Screeners with CASI included

    Growing Shares Outstanding
    Best performing stocks last month
    Chinese stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for CASI Pharmaceuticals, Inc.?
    • Does CASI Pharmaceuticals, Inc. pay dividends?
    • What sector is CASI Pharmaceuticals, Inc. in?
    • What industry is CASI Pharmaceuticals, Inc. in?
    • What country is CASI Pharmaceuticals, Inc. based in?
    • When did CASI Pharmaceuticals, Inc. go public?
    • Is CASI Pharmaceuticals, Inc. in the S&P 500?
    • Is CASI Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is CASI Pharmaceuticals, Inc. in the Dow Jones?
    • When was CASI Pharmaceuticals, Inc.'s last earnings report?
    • When does CASI Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for CASI Pharmaceuticals, Inc.?

    The ticker symbol for CASI Pharmaceuticals, Inc. is NASDAQ:CASI

    Does CASI Pharmaceuticals, Inc. pay dividends?

    No, CASI Pharmaceuticals, Inc. does not pay dividends

    What sector is CASI Pharmaceuticals, Inc. in?

    CASI Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is CASI Pharmaceuticals, Inc. in?

    CASI Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is CASI Pharmaceuticals, Inc. based in?

    CASI Pharmaceuticals, Inc. is headquartered in China

    When did CASI Pharmaceuticals, Inc. go public?

    CASI Pharmaceuticals, Inc.'s initial public offering (IPO) was on June 12, 1996

    Is CASI Pharmaceuticals, Inc. in the S&P 500?

    No, CASI Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is CASI Pharmaceuticals, Inc. in the NASDAQ 100?

    No, CASI Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is CASI Pharmaceuticals, Inc. in the Dow Jones?

    No, CASI Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was CASI Pharmaceuticals, Inc.'s last earnings report?

    CASI Pharmaceuticals, Inc.'s most recent earnings report was on May 16, 2025

    When does CASI Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for CASI Pharmaceuticals, Inc. is August 20, 2025
    On this page